Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Srx246
1. Srx246
2. 512784-93-9
3. Srx 246
4. 372x2p22uy
5. Dtxsid701032257
6. Refchem:185218
7. Dtxcid001517266
8. (alphar)-gamma-oxo-alpha-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)(1,4'-bipiperidine)-1'-butanamide
9. (1,4'-bipiperidine)-1'-butanamide, Gamma-oxo-alpha-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-, (alphar)-
10. Gamma-oxo-alpha-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-(alphar)-(1,4'-bipiperidine)-1'-butanamide
11. (2r)-4-oxo-2-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl)-4-((1e)-2-phenylethenyl)azetidin-1-yl)-n-((1s)-1-phenylethyl)-4-(4-(2-(piperidin-1-yl)ethyl)piperidin-1-yl)butanamide
12. Unii-372x2p22uy
13. Chembl395817
14. (2r)-4-oxo-2-[(3s,4r)-2-oxo-3-[(4s)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-4-[(e)-2-phenylethenyl]azetidin-1-yl]-n-[(1r)-1-phenylethyl]-4-(4-piperidin-1-ylpiperidin-1-yl)butanamide
15. Orb1706602
16. Schembl14198966
17. Bdbm50202920
18. Ex-a12241
19. Nsc782566
20. Akos040742647
21. Nsc-782566
22. Da-58079
23. Ms-31178
24. Hy-105685
25. Cs-0026445
26. G17232
27. (.alpha.r)-.gamma.-oxo-.alpha.-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)(1,4'-bipiperidine)-1'-butanamide
28. (1,4'-bipiperidine)-1'-butanamide, .gamma.-oxo-.alpha.-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-, (.alpha.r)-
29. .gamma.-oxo-.alpha.-((3s,4r)-2-oxo-3-((4s)-2-oxo-4-phenyl-3-oxazolidinyl)-4-((1e)-2-phenylethenyl)-1-azetidinyl)-n-((1r)-1-phenylethyl)-(.alpha.r)-(1,4'-bipiperidine)-1'-butanamide
30. 2(r)-[[4-(piperidin-1-yl)piperidin-1-yl]carbonylmethyl]-2-[3(s)-(4(s)-phenyloxazolidin-2-on-3-yl)-4(r)-(2-styryl)azetidin-2-on-1-yl]acetic Acid N-[(r)-alpha-methylbenzyl]amide
| Molecular Weight | 703.9 g/mol |
|---|---|
| Molecular Formula | C42H49N5O5 |
| XLogP3 | 5.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 103 |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1260 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidiuretic Hormone Receptor Antagonists
Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS.
ABOUT THIS PAGE